This paper presents our contributions to the Speech Emotion Recognition in Naturalistic Conditions (SERNC) Challenge, where we address categorical emotion recognition and emotional attribute prediction. To handle the complexities of natural speech, including intra- and inter-subject variability, we propose Multi-level Acoustic-Textual Emotion Representation (MATER), a novel hierarchical framework that integrates acoustic and textual features at the word, utterance, and embedding levels. By fusing low-level lexical and acoustic cues with high-level contextualized representations, MATER effectively captures both fine-grained prosodic variations and semantic nuances. Additionally, we introduce an uncertainty-aware ensemble strategy to mitigate annotator inconsistencies, improving robustness in ambiguous emotional expressions. MATER ranks fourth in both tasks with a Macro-F1 of 41.01% and an average CCC of 0.5928, securing second place in valence prediction with an impressive CCC of 0.6941.

Accurate early screening of Alzheimer’s disease (AD) is crucial, yet traditional diagnostic methods are often limited by invasiveness or high costs. Therefore, there is a critical need for non-invasive biomarkers that enable precise and accessible screening. In this study, we propose a multi-modal digital biomarker framework designed to accurately detect AD by evaluating impairments across multiple cognitive domains, such as language, working memory, and visuospatial attention. By leveraging voice and video data, our approach significantly enhances user accessibility and real-world applicability. We validated the proposed framework using a dataset of 128 participants, comprising 77 healthy controls (HCs) and 51 patients with AD. While individual cognitive tasks yielded F1-scores ranging from 69.23% to 77.78% and sensitivities from 69.23% to 80.77%, our ensemble strategy significantly enhanced detection performance, achieving an F1-score of 83.64% and a sensitivity of 88.46%. These findings confirm that the proposed multi-modal digital biomarker framework, enhanced via ensembling, provides a highly accurate, scalable, and practical solution for the non-invasive screening and detection of AD.